Skip to main content

Advertisement

Log in

Dramatic development of severe SLE in a patient with an incomplete disease

  • Case Report
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

This case report describes the previously-unreported clinical course of a patient with a so-called incomplete systemic lupus erythematosus (SLE), i.e. symptoms related to one organ system only, together with the presence of ANA. He had an indolent course initially and developed, 6 months after the first symptoms, a severe disease with rapid appearance of major and unusual manifestations. The possibility of fast progression and a grave course of an incomplete SLE should be kept in mind. This report is meant to heighten awareness of such an atypical presentation so that prompt and aggressive immunosuppressive therapy may be instituted.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Swaak AJ, van de Brink H, Smeenk RJ, Manger K, Kalden JR, Tosi S, Marchesoni A, Domljan Z, Rozman B, Logar D, Pokorny G, Kovacs L, Kovacs A, Vlachoyiannopoulos PG, Moutsopoulos HM, Chwalinska-Sadowska H, Dratwianka, Kiss E, Cikes N, Anic B, Schneider M, Fischer R, Bombardieri S, Mosca M, Graninger W, Smolen JS (2001) Study group on incomplete SLE and SLE with disease duration longer than 10 years. Incomplete lupus erythematosus: results of a multicentre study under the supervision of the EULAR standing committee on international clinical studies including therapeutic trials (ESCISIT). Rheumatology 40:89–94

    Article  Google Scholar 

  2. Drenkard C, Villa AR, Reyes E, Abello M, Alarcon-Segovia D (1997) Vasculitis in systemic lupus erytemathematosus. Lupus 6:235–242

    Google Scholar 

  3. Hallegua DS, Wallace DJ (2000) Gastrointestinal manifestations in systemic lupus erythematosus. Curr Opin Rheumatol 12:379–385

    Article  Google Scholar 

  4. Lee CK, Ahn MS, Lee EY, Shin JH, Cho YS, Ha HK, Yoo B, Moon HB (2002) Acute abdominal pain in systemic lupus erythematosus: focus on lupus enteritis (gastrointestinal vasculitis). Ann Rheum Dis 61:547–550

    Article  Google Scholar 

  5. Tanaka H, Waga S, Tateyama T, Nakahata T, Ito T, Sugimoto K, Kakizaki Y, Tomimoto K, Yokoyama M (2000) Interstitial cystitis and ileus in pediatric-onset systemic lupus erythematosus. Pediatr Nephrol 14:859–861

    Article  Google Scholar 

  6. Hirashi H, Konishi T, Ota S, Shimada T, Terano A, Sugimoto T (1999) Massive gastrointestinal hemorrhage in systemic lupus erythematosus: successful treatment with corticosteroid pulse therapy. Am J Gastroenterol 94:3359–3363

    Article  CAS  PubMed  Google Scholar 

  7. Grimbacher B, Huber M, Kempis J, Kalden P, Uhl M, Kohler H, Blum HE, Peter HH (1998) Successful treatment of gastrointestinal vasculitis due to systemic lupus erythematosus with intravenous pulse cyclophosphamide: a clinical case report and review of the literature. Br J Rheumatol 37:1023–1028

    Article  Google Scholar 

  8. Wheatley MJ, Hennein HA, Greenfield LJ (1991) Lower extremity arterial disease in systemic lupus erythematosus. Arch Surg 126:109–110

    Google Scholar 

  9. Glueck HI, Kant KS, Weiss MA, Pollack, Miller MA, Coots M (1985) Thrombosis in systemic lupus erythematosus: relations to the presence of circulating anticoagulants. Arch Intern Med 145:389–1395

    Article  Google Scholar 

  10. Refai TMK, Al-Salem IH, Nkansa-Dwamena D, Al-Salem MH (2002) Hyperhomocysteinaemia and risk of thrombosis in systemic lupus erythematosus patients. Clin Rheumatol 21:457–461

    Article  Google Scholar 

  11. Walker G, Merry P, Sethia K, Ball RY (2000) A case of testicular lupus. Lupus 9:397–398

    Article  Google Scholar 

  12. Kuehn MW, Oellinger R, Kustin G, Merkel KH (1989) Primary testicular manifestation of systemic lupus erythematosus. Eur Urol 16:72–73

    Google Scholar 

  13. Göbel U, Kettritz R, Schneider W, Luft FC (2002) A particular private pain. Nephrol Dial Transplant 17:516–518

    Article  Google Scholar 

  14. Ochonisky S, Intator L, Wechsler J, Revuz J, Bagot M (1993) Acquired C1 inhibitor deficiency revealing systemic lupus erythematosus. Dermatology 186:261–263

    Google Scholar 

  15. Thong BYH, Thumboo J, Howe HS, Feng PH (2001) Life-threatening angioedema in systemic lupus erythematosus. Lupus 10:304–308

    Article  Google Scholar 

  16. Hidalgo-Tenorio C, Sabio JM, Jaimez L, Jeménez-Alonso J (2001) Achalasia, angioedema and systemic lupus erythematosus. Lupus 10:831–832

    Google Scholar 

  17. Cacoub P, Fremeaux-Bacchi V, De Lacroix I, Guillien F, Kahn MF, Kazatchkine MD, Godeau P, Piette JC (2001) A new type of acquired C1 deficiency associated with systemic lupus erythematosus. Arthritis Rheum 4:1836–1840

    Article  Google Scholar 

  18. Jazwinska E, Gatenby P, Dunckley H, Serjeantson S (1993) C1 inhibitor functional deficiency in systemic lupus erythematosus (SLE). Clin Exp Immunol 92:268–273

    Google Scholar 

  19. Pereira RMR,Velloso ERP, Menezes Y, Gualandro S, Vassalo J, Yoshinari NH (1998) Bone marrow findings in systemic lupus erythematosus patients with peripheral cytopenias. Clin Rheumatol 17:219–222

    Google Scholar 

  20. Hellmich B, Csernok E, Schatz H, Gross WL, Schnabel A (2002) Autoantibodies against granulocyte colony-stimulating factor in Felty’s Syndrome and neutropenic. Syst Lupus Erythematosus. Arthr Rheum 46:2384–2391

    Google Scholar 

Download references

Acknowledgements

This work was supported by Università degli Studi di Milano (FIRST) and IRCCS Ospedale Maggiore di Milano (Ricerca Corrente).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G Fabio.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fabio, G., Carrabba, M., Hu, C. et al. Dramatic development of severe SLE in a patient with an incomplete disease. Rheumatol Int 25, 543–547 (2005). https://doi.org/10.1007/s00296-004-0550-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-004-0550-1

Keywords

Navigation